Bispecific Antibody Overview and Production with CrossMab Technology

In this webinar, Dr. Sai Wang, protein senior scientist at GenScript Biotech Singapore, will discuss the advantages of bispecific antibodies (bsAbs), their mechanism of action (MOA), and the development history of bsAb platform. She will also help attendees to gain an understanding of the CrossMab production method and its significance in the field of antibody engineering. Additionally, Dr. Wang will provide case studies related to CrossMab production, that offer practical knowledge about the optimization of manufacturing processes of bsAbs.

Key learning objectives

• Gain an understanding of bispecific antibodies (bsAbs)
• Explore bsAbs’ mechanism of action and its development history
• Learn about CrossMab production with related case studies

Who should attend?

Researchers, scientists, and professionals working in the biopharmaceutical industry who are interested in bsAb expression.

Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.